Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10503338 | 0.77 | TET2 (0.48) | ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2 | |
| SCHEMBL22490940 | 0.76 | TDP1 (0.36) | TDP1 | |
| SCHEMBL30906961 | 0.76 | TDP1 (0.31) | TDP1 | |
| SCHEMBL5668482 | 0.74 | TDP1 (0.36) | TDP1ALDH1A1LMNAOR51E2 | |
| SCHEMBL22607749 | 0.73 | TDP1 (0.33) | TDP1 | |
| Tromethamine SCHEMBL6263020 | 0.73 | MEN1 (0.42) | LMNA | |
| SCHEMBL15742308 | 0.73 | ALDH1A1 (0.35) | TDP1ALDH1A1TP53CYP3A4MAPK1 | |
| SCHEMBL1695816 | 0.72 | TET2 (0.35) | TDP1ALDH1A1LMNAOR51E2 | |
| SCHEMBL4342621 | 0.72 | TDP1 (0.63) | TDP1ALDH1A1TP53CYP3A4MAPK1 | |
| SCHEMBL3232065 | 0.72 | TDP1 (0.41) | TDP1ALDH1A1LMNAOR51E2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024015644-A1 | BIOPHARMACEUTICAL FORMULATIONS INCLUDING POLYMER EXCIPIENTS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2024-01-18 | — | — | WO | disclosed |